D. Beaulieu

发表

Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling

Tatsuki Koyama, Elizabeth A. Scoville, Dawn B. Beaulieu, 2017, Metabolomics.

L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis

Dawn B. Beaulieu, Lori A. Coburn, D. Schwartz, 2016, Inflammatory bowel diseases.

Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of Life

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2020, Crohn's & colitis 360.

History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis

Dawn B. Beaulieu, A. Ananthakrishnan, D. Binion, 2008, Inflammatory bowel diseases.

A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD)

Dawn B. Beaulieu, C. Quinn, M. Regueiro, 2018, The American Journal of Gastroenterology.

Precision nicotine metabolism-informed care for smoking cessation in Crohn’s disease: A pilot study

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2020, PloS one.

Age Modifies the Association Between Depressive Symptoms and Adherence to Self-Testing With Telemedicine in Patients With Inflammatory Bowel Disease.

Dawn B. Beaulieu, C. Quinn, M. Regueiro, 2018, Inflammatory bowel diseases.

Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab

Dawn B. Beaulieu, D. Schwartz, Leyla J. Ghazi, 2016, Inflammatory bowel diseases.

Inflammatory bowel disease in pregnancy.

Dawn B. Beaulieu, S. Kane, D. Beaulieu, 2011, World journal of gastroenterology.

Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease?

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2019, Inflammatory bowel diseases.

Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn’s Disease

Christopher F. Martin, Dawn B. Beaulieu, D. Schwartz, 2016, The American Journal of Gastroenterology.

Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing

Dawn B. Beaulieu, D. Schwartz, A. Herline, 2015, Inflammatory bowel diseases.

Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease

Dawn B. Beaulieu, D. Schwartz, Robin L. Dalal, 2017, Digestive Diseases and Sciences.

Functional Medicine Approach to Patient Care Improves Sleep, Fatigue, and Quality of Life in Patients With Inflammatory Bowel Disease

Elizabeth A. Scoville, Dawn B. Beaulieu, Robin L. Dalal, 2022, Crohn's & colitis 360.

Budesonide induction and maintenance therapy for Crohn's disease during pregnancy

Dawn B. Beaulieu, A. Ananthakrishnan, D. Binion, 2009, Inflammatory bowel diseases.

A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2020, Crohn's & colitis 360.

The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn's Disease.

Elizabeth A. Scoville, Dawn B. Beaulieu, Alexander P. Mamunes, 2021, Inflammatory bowel diseases.

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines

Christopher F. Martin, Dawn B. Beaulieu, A. Ananthakrishnan, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy.

Dawn B. Beaulieu, N. Halasa, H. Talbot, 2016, Journal of the Pediatric Infectious Diseases Society.

Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience

Elizabeth A. Scoville, Dawn B. Beaulieu, D. Schwartz, 2021, Digestive Diseases and Sciences.

Inflammatory bowel disease in pregnancy.

Dawn B. Beaulieu, S. Kane, D. Beaulieu, 2011, Gastroenterology clinics of North America.

Durability of infliximab in Crohn's disease: A single‐center experience

Dawn B. Beaulieu, A. Ananthakrishnan, D. Binion, 2009, Inflammatory bowel diseases.

Mo1376 Depression and the Cost of Outpatient Treatment of Crohn's Disease in an US Academic Medical Center

D. Schwartz, R. Stiles, I. Ray, 2013 .

W1315 Re-Capturing Response With Micro-Reinduction of Adalimumab: A Tertiary Care Center Experience

D. Schwartz, A. Ananthakrishnan, J. Slaughter, 2010 .

Vedolizumab Concentrations in Breast Milk: Results from a Prospective, Postmarketing, Milk-Only Lactation Study in Nursing Mothers with Inflammatory Bowel Disease

Dawn B. Beaulieu, R. Arsenescu, D. Beaulieu, 2021, Clinical Pharmacokinetics.

Rifaximin and Treatment of Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: 1206

Dawn B. Beaulieu, D. Binion, D. Beaulieu, 2006 .

Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments

Dawn B. Beaulieu, D. Schwartz, Scott A. Merkley, 2015, Inflammatory bowel diseases.

MTG16 contributes to colonic epithelial integrity in experimental colitis

Dawn B. Beaulieu, Lori A. Coburn, M. Washington, 2012, Gut.